Amicus Therapeutics (FOLD) PT Lowered to $19 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Elemer Piros lowered the price target on Amicus Therapeutics (NASDAQ: FOLD) to $19.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
